Publications

99 rows, counting the CV or the Scholar profile
Export

Core

Profile fields

Catalogue

2026 A drug–microbiome–drug interaction impacts co-prescribed medications for Parkinson’s disease Jason M. Crawford · Nature Microbiology · Scholar only 5 2025 Activity of GPCR-targeted drugs influenced by human gut microbiota metabolism Jason M. Crawford · Nature chemistry · Scholar only 25 2025 Bacterial small molecule metabolites implicated in gastrointestinal cancer development Jason M. Crawford · Nature Reviews Microbiology · Scholar only 21 2025 Human AKR1C3 binds agonists of GPR84 and participates in an expanded polyamine pathway Jason M. Crawford · Cell chemical biology 32 (1), 126-144. e18 · Scholar only 7 2025 Three-component assembly and structure-function relationships of (–)-gukulenin A Jason M. Crawford · Science · Scholar only 5 2025 Tryptamine metabolism and functionalization in Gut commensal bacteria expand human tryptamine signaling responses Jason M. Crawford · ACS Chemical Biology · Scholar only 6 2024 Enterococcus faecalis-derived adenine enhances enterohaemorrhagic Escherichia coli Type 3 Secretion System-dependent virulence Jason M. Crawford · Nature microbiology · Scholar only 13 2024 IL-10 constrains sphingolipid metabolism to limit inflammation Jason M. Crawford · Nature · Scholar only 285 2024 Latrophilin-2 mediates fluid shear stress mechanotransduction at endothelial junctions Jason M. Crawford · The EMBO journal · Scholar only 31 2024 Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers Jason M. Crawford · Journal of the American Chemical Society · Scholar only 15 2024 Mucosal sugars delineate pyrazine vs pyrazinone autoinducer signaling in Klebsiella oxytoca Jason M. Crawford · Nature communications · Scholar only 8 2024 Proof-of-concept studies with a computationally designed Mpro inhibitor as a synergistic combination regimen alternative to Paxlovid Jason M. Crawford · Proceedings of the National Academy of Sciences · Scholar only 14 2023 Gut microbes modulate (p) ppGpp during a time-restricted feeding regimen Jason M. Crawford · Mbio · Scholar only 9 2023 IL-10 constrains sphingolipid metabolism via fatty acid desaturation to limit inflammation Jason M. Crawford · bioRxiv, 2023.05 · Scholar only 6 2022 Cellular stress-induced metabolites in escherichia coli Jason M. Crawford · Journal of natural products · Scholar only 11 2022 Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites Jason M. Crawford · Science · Scholar only 276 2022 Cross-kingdom expression of synthetic genetic elements promotes discovery of metabolites in the human microbiome Jason M. Crawford · Cell 185 (9), 1487-1505. e14 · Scholar only 56 2022 Fossil biomolecules reveal an avian metabolism in the ancestral dinosaur Jason M. Crawford · Nature · Scholar only 98 2022 LACC1 bridges NOS2 and polyamine metabolism in inflammatory macrophages Jason M. Crawford · Nature · Scholar only 78 2022 N‐Acyl Amides from Neisseria meningitidis and Their Role in Sphingosine Receptor Signaling Jason M. Crawford · Chembiochem · Scholar only 14 2022 RNA m6A demethylase ALKBH5 regulates the development of γδ T cells Jason M. Crawford · Proceedings of the National Academy of Sciences · Scholar only 62 2021 A community resource for paired genomic and metabolomic data mining Jason M. Crawford · Nature Chemical Biology · Scholar only 151 2021 A conserved nonribosomal peptide synthetase in Xenorhabdus bovienii produces citrulline-functionalized lipopeptides Jason M. Crawford · Journal of natural products · Scholar only 20 2021 Escherichia coli-derived γ-lactams and structurally related metabolites are produced at the intersection of colibactin and fatty acid biosynthesis Jason M. Crawford · Organic letters · Scholar only 10 2021 Escherichia coli small molecule metabolism at the host–microorganism interface Jason M. Crawford · Nature chemical biology · Scholar only 46 2021 Molecules from the microbiome Jason M. Crawford · Annual review of biochemistry · Scholar only 65 2021 Natural Products: An Era of Discovery in Organic Chemistry Jason M. Crawford · The Journal of Organic Chemistry · Scholar only 11 2020 A DNA repair inhibitor isolated from an Ecuadorian fungal endophyte exhibits synthetic lethality in PTEN-deficient Glioblastoma Jason M. Crawford · Journal of natural products · Scholar only 8 2020 Bacterial autoimmune drug metabolism transforms an immunomodulator into structurally and functionally divergent antibiotics Jason M. Crawford · Angewandte Chemie International Edition · Scholar only 33 2020 Cellular stress upregulates indole signaling metabolites in Escherichia coli Jason M. Crawford · Cell chemical biology 27 (6), 698-707. e7 · Scholar only 34 2020 Characterization of autoinducer-3 structure and biosynthesis in E. coli Jason M. Crawford · ACS central science · Scholar only 185 2020 Dimeric stilbene antibiotics target the bacterial cell wall in drug-resistant gram-positive pathogens Jason M. Crawford · Biochemistry · Scholar only 16 2020 Dual targeting of v-ATPase and mTORC1 signaling disarms multidrug-resistant cancers Jason M. Crawford · Cell chemical biology · Scholar only 4 2020 Latrophilins are essential for endothelial junctional fluid shear stress mechanotransduction Jason M. Crawford · bioRxiv, 2020.02 · Scholar only 6 2020 Making and breaking leupeptin protease inhibitors in pathogenic Gammaproteobacteria Jason M. Crawford · Angewandte Chemie International Edition · Scholar only 24 2020 Phylogenetic and physiological signals in metazoan fossil biomolecules Jason M. Crawford · Science Advances 6 (28), eaba6883 · Scholar only 61 2020 Structure and bioactivity of colibactin Jason M. Crawford · Bioorganic & medicinal chemistry letters · Scholar only 94 2020 Sulfamethoxazole drug stress upregulates antioxidant immunomodulatory metabolites in Escherichia coli Jason M. Crawford · Nature microbiology · Scholar only 45 2019 A forward chemical genetic screen reveals gut microbiota metabolites that modulate host physiology Jason M. Crawford · Cell 177 (5), 1217-1231. e18 · Scholar only 405 2019 An Ugi-like biosynthetic pathway encodes bombesin receptor subtype-3 agonists Jason M. Crawford · Journal of the American Chemical Society · Scholar only 16 2019 Bacterial analogs of plant tetrahydropyridine alkaloids mediate microbial interactions in a rhizosphere model system Jason M. Crawford · Applied and Environmental Microbiology · Scholar only 44 2019 Biocatalytic Reversal of Advanced Glycation End Product Modification Jason M. Crawford · ChemBioChem · Scholar only 17 2019 Bright green biofluorescence in sharks derives from bromo-kynurenine metabolism Jason M. Crawford · IScience · Scholar only 38 2019 Characterization of a Hybrid Nonribosomal Peptide–Carbohydrate Biosynthetic Pathway in Photorhabdus luminescens Jason M. Crawford · Biochemistry · Scholar only 9 2019 Disruption of mosGILT in Anopheles gambiae impairs ovarian development and Plasmodium infection Jason M. Crawford · Journal of Experimental Medicine · Scholar only 36 2019 Introducing THOR, a model microbiome for genetic dissection of community behavior Jason M. Crawford · MBio 10 (2), 10.1128/mbio · Scholar only 88 2019 Structure elucidation of colibactin Jason M. Crawford · bioRxiv · Scholar only 7 2019 Structure elucidation of colibactin and its DNA cross-links Jason M. Crawford · Science · Scholar only 297 2019 Synthesis and reactivity of precolibactin 886 Jason M. Crawford · Nature Chemistry · Scholar only 46 2018 Characterization of Natural Colibactin–Nucleobase Adducts by Tandem Mass Spectrometry and Isotopic Labeling. Support for DNA Alkylation by Cyclopropane Ring Opening Jason M. Crawford · Biochemistry · Scholar only 53
Back to the list

2026 · other · journal

A drug–microbiome–drug interaction impacts co-prescribed medications for Parkinson’s disease

Nature Microbiology · Jason M. Crawford

on Scholar
5Scholar citations
noneOpenAlex citations

From the CV

Not in the CV.

Where each field came from

FieldCVOpenAlexScholar
title A drug–microbiome–drug interaction impacts co-prescribed medications for Parkinson’s disease (used)
year 2026 (used)
venue Nature Microbiology (used)
kind other (used)
first author Verdegaal (used)

The value in bold is the one the record uses.

How the records were joined

No decision recorded; a single record.